AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Ingredion Inc

Regulatory Filings May 23, 2025

Preview not available for this file type.

Download Source File

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

____

FORM 8-K

____

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 21, 2025

____

INGREDION INCORPORATED

(Exact name of registrant as specified in its charter)

____

Delaware 1-13397 22-3514823
(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)
5 Westbrook Corporate Center, Westchester, Illinois 60154
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: ( 708 ) 551-2600

Not Applicable

(Former name or former address, if changed since last report)

____

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per share INGR New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07 Submission of Matters to a Vote of Security Holders.

(a) On May 21, 2025, at the 2025 annual meeting of stockholders (the “2025 annual meeting”) of Ingredion Incorporated (the “Company”), the Company’s stockholders voted on three proposals, which are described in the proxy statement for the 2025 annual meeting filed with the Securities and Exchange Commission on April 9, 2025 (the “2025 proxy statement”).

(b) As of the record date for the 2025 annual meeting, an aggregate of 64,299,712 shares of the Company’s common stock were outstanding and entitled to vote at the meeting. Each share of common stock is entitled to one vote per share.

The final voting results with respect to each proposal voted upon at the 2025 annual meeting are set forth below.

Proposal 1

The holders of the outstanding shares of the Company’s common stock elected to the Company’s Board of Directors each of the 11 nominees specified in the 2025 proxy statement, based on the following numbers of votes:

Name For Against Abstentions Broker Non-Votes
David B. Fisher 52,132,151 1,438,379 272,157 3,796,591
Rhonda L. Jordan 51,379,768 2,188,485 274,434 3,796,591
Gregory B. Kenny 51,066,577 1,795,784 980,326 3,796,591
Charles V. Margo 52,726,929 841,620 274,138 3,796,591
Victoria J. Reich 52,278,773 1,288,595 275,319 3,796,591
Catherine A. Suever 52,816,774 757,965 267,948 3,796,591
Stephan B. Tanda 52,597,415 968,885 276,387 3,796,591
Jorge A. Uribe 52,533,292 977,433 331,962 3,796,591
Patricia Verduin 52,603,641 950,229 288,817 3,796,591
Dwayne A. Wilson 51,040,745 2,528,221 273,721 3,796,591
James P. Zallie 52,331,078 1,240,347 271,262 3,796,591

Each nominee elected to the Board of Directors at the 2025 annual meeting was elected for a term of one year and until his or her successor has been elected and qualified or until the director’s earlier death, resignation, or removal.

Proposal 2

The holders of the outstanding shares of the Company’s common stock approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the 2025 proxy statement, based on the following numbers of votes:

For Against Abstentions Broker Non-Votes
50,840,164 2,679,283 323,240 3,796,591

Proposal 3

The holders of the outstanding shares of the Company’s common stock ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025, based on the following numbers of votes:

For Against Abstentions
54,612,654 2,963,844 62,780

There were no broker non-votes with respect to this proposal.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: May 23, 2025
By: /s/ Tanya M. Jaeger de Foras
Tanya M. Jaeger de Foras Senior Vice President, Chief Legal Officer, Corporate Secretary and Chief Compliance Officer

Talk to a Data Expert

Have a question? We'll get back to you promptly.